Subsidiary of Green Cross Holdings Acquires 1,000 Shares of US Contract Manufacturer for 90 Billion Won

[Asia Economy Reporter Ryu Tae-min] Green Cross Holdings announced on the 19th that its subsidiary COERA will acquire 1,000 shares of BIOCENTRIQ, a US contract manufacturing organization for cell therapy products, for approximately 90 billion KRW. After the acquisition, the ownership stake will be 100%.

Green Cross Holdings stated that the purpose of this stock acquisition is to "enter the US cell therapy CDMO market."